BACK TO TOP

Clinical Research Canada

With this branch office, Criterium continues to extend its worldwide clinical trials capabilities to Canada, a long established and steadily growing area for clinical research studies. Canada's dynamic G8 economy continues to demonstrate its strong fundamentals and world-leading capabilities in a range of sectors, including information technology, engineering, biotech, and aerospace. Canada’s position as a biotechnology leader—one of the top five countries in the world—is a reflection of the country’s world-class credentials.

Canada recognizes the economic potential of the biotech industry and has formally committed itself to become one of the top five countries in the world for biotech research and development. With an 8% annual growth rate, Canada is the fourth fastest growing market in the world for pharmaceuticals. The sector benefits from Canada’s thriving biotechnology industry, which also fuels pharmaceutical companies’ growth. Add to these advantages a well-educated workforce, highly-trained scientists and technicians, business-friendly government policies -- nearly every major pharmaceutical company has manufacturing and/or R&D operations in Canada.

  • Globally-recognized industry
  • A vital, proactive approach to R&D
  • Facilitated access to export markets

A Snapshot of the Canadian Biotech Sector

  • 496 biotechnology companies, public firms making up 17%
  • $3.8 billion in biotech revenues, a 96% increase over 1999
  • 17,065 products/processes at all stages of development; of these, nearly 2/3 on the market
  • $1.5 billion in R&D spending by industry, an 80% increase over 1999
  • Public biotechnology firms increased R&D spending by 224% over 1998
  • Annual federal biotechnology spending $791 million, 96% of it on R&D (2004-05)
  • Human health dominates the Canadian biotechnology scene, accounting for 53% of firms:
    • Biopharmaceutical sales—$2.1 Billion
    • Over 78% of all biotechnology-related jobs are in this sector. (176 bio-pharmaceutical firms—2006)
    • Nearly 90% of R&D investments in biotech is dedicated solely to this sector. (Biopharma R&D—$1.3 Million)
  • Toronto has the largest faculty of medicine in North America and the output of peer-reviewed publications from this area is greater than any other medical centre in the world.

Research Successes in Canada

  • A team from the Faculty of Medicine at Centre Hospitalier universitaire de Québec at Université Laval recently discovered a natural defense mechanism in the body deployed to combat nerve cell degeneration observed in people with Alzheimer’s disease. The discovery could lead to a new therapeutic approach to Alzheimer’s disease.
  • University of Toronto biomedical scientists have pioneered the genetic mechanisms for several diseases and discovered a way to increase the yield of stem calls from umbilical cord blood by removing unwanted cells that inhibit stem cell growth.
  • Scientists at McGill University have discovered a gene that controls the speed at which patients develop tuberculosis. This is a breakthrough in understanding how a gene can control the time frame between initial infection and the disease.
  • A BC neuroscientist developed the world’s first diagnostic blood test to detect diseases such as Alzheimer’s, Parkinson’s, Lou Gehrigs and CJV.
  • An international team led by three University of British Columbia microbiologists has completed the mapping of the genetic makeup of a soil bacterium (RHA 1), the first organism of its kind to be completely sequenced. This work illuminates how the soil organism breaks down PCBs and other toxic wastes, and adapts to the environment around it. (source: http://investincanada.gc.ca/eng/industry-sectors/biotechnology.aspx)

Therapeutic Expertise

Criterium Inc conducts National and Multi-National Clinical Trials in a wide range of Therapeutic Areas. Our personnel have participated in over 500 studies. Here is a selected list of previous studies:

  • Allergy
  • Respiratory
  • Dermatology
  • Cardiovascular Disease
  • Ophthalmology
  • Women’s Studies
  • Urology
  • Pain Management
  • HIV/ Infectious Disease
  • Central Nervous System
  • Internal Medicine
  • Oncology
  • Metabolic Disease
  • Hematology

Service Expertise

All Criterium clients benefit from our efficient technology-based workflow. Field staff in Canada are supported by centralized Remote Study Management, Data Management, Statistical Analysis, and Programming Support services in Criterium’s New York headquarters.
Because of this strong support structure the data are locked sooner, allowing for statistical analysis, final reports and speedy submission of studies to the client and agencies. This enables us to set aggressive timelines, reduce costs and produce very high quality data when completing the clinical trial process.
Some of the specialized services Criterium provides include:

  • Regulatory Services
  • Clinical Study Management
  • Data Management
  • Statistics and Programming
  • Pharmacokinetics/Pharmacodynamics – Local Phase I / BE / BA Studies
  • Medical Writing
  • Program Management

Regulatory Expertise

With experienced personnel including Board Certified Physicians in each region, Criterium clients benefit from our thorough understanding of the unique regulatory structures and specialized patient requirements of each country in which we work.

Clinical Trials Canada
Contact info

GET TO KNOW US!

DOWNLOAD OUR BROCHURE